Hexagonal Stimulation Digital Controller Design and Verification for Wireless Subretinal Implant Device

Significant progress has been made in the field of micro/nano-retinal implant technologies. However, the high pixel range, power leakage, reliability, and lifespan of retinal implants are still questionable. Active implantable devices are safe, cost-effective, and reliable. Although a device that ca...

Full description

Bibliographic Details
Main Authors: Abbasi, W. (Author), Choi, H. (Author), Kim, J. (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 02525nam a2200409Ia 4500
001 0.3390-s22082899
008 220421s2022 CNT 000 0 und d
020 |a 14248220 (ISSN) 
245 1 0 |a Hexagonal Stimulation Digital Controller Design and Verification for Wireless Subretinal Implant Device 
260 0 |b MDPI  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.3390/s22082899 
520 3 |a Significant progress has been made in the field of micro/nano-retinal implant technologies. However, the high pixel range, power leakage, reliability, and lifespan of retinal implants are still questionable. Active implantable devices are safe, cost-effective, and reliable. Although a device that can meet basic safety requirements set by the Food and Drug Administration and the European Union is reliable for long-term use and provides control on current and voltage parameters, it will be expensive and cannot be commercially successful. This study proposes an economical, fully controllable, and configurable wireless communication system based on field-programmable gated arrays (FPGAs) that were designed with the ability to cope with the issues that arise in retinal implantation. This system incorporates hexagonal biphasic stimulation pulses generated by a digital controller that can be fully controlled using an external transmitter. The integration of two separate domain analog systems and a digital controller based on FPGAs is proposed in this study. The system was also implemented on a microchip and verified using in vitro results. © 2022 by the authors. Licensee MDPI, Basel, Switzerland. 
650 0 4 |a Controlled drug delivery 
650 0 4 |a Controllers 
650 0 4 |a Cost effectiveness 
650 0 4 |a digital controller 
650 0 4 |a Digital controller designs 
650 0 4 |a Digital controllers 
650 0 4 |a Field programmable gate arrays (FPGA) 
650 0 4 |a Field programmables 
650 0 4 |a Field-programmable gated array 
650 0 4 |a field-programmable gated arrays 
650 0 4 |a hexagonal stimulation 
650 0 4 |a Hexagonal stimulation 
650 0 4 |a Implant devices 
650 0 4 |a Implants (surgical) 
650 0 4 |a Integrated circuit design 
650 0 4 |a Micro/nano 
650 0 4 |a Ophthalmology 
650 0 4 |a Retinal implant technology 
650 0 4 |a Subretinal implants 
650 0 4 |a wireless telemetry system 
650 0 4 |a Wireless telemetry systems 
700 1 0 |a Abbasi, W.  |e author 
700 1 0 |a Choi, H.  |e author 
700 1 0 |a Kim, J.  |e author 
773 |t Sensors